311 related articles for article (PubMed ID: 25813014)
1. Dual-time-point O-(2-[(18)F]fluoroethyl)-L-tyrosine PET for grading of cerebral gliomas.
Lohmann P; Herzog H; Rota Kops E; Stoffels G; Judov N; Filss C; Galldiks N; Tellmann L; Weiss C; Sabel M; Coenen HH; Shah NJ; Langen KJ
Eur Radiol; 2015 Oct; 25(10):3017-24. PubMed ID: 25813014
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic accuracy of detecting malignant transformation of low-grade glioma using O-(2-[18F]fluoroethyl)-l-tyrosine positron emission tomography: a retrospective study.
Bashir A; Brennum J; Broholm H; Law I
J Neurosurg; 2018 Apr; 130(2):451-464. PubMed ID: 29624154
[TBL] [Abstract][Full Text] [Related]
3. Comparison of
Verger A; Filss CP; Lohmann P; Stoffels G; Sabel M; Wittsack HJ; Kops ER; Galldiks N; Fink GR; Shah NJ; Langen KJ
Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2257-2265. PubMed ID: 28831534
[TBL] [Abstract][Full Text] [Related]
4. Early static (18)F-FET-PET scans have a higher accuracy for glioma grading than the standard 20-40 min scans.
Albert NL; Winkelmann I; Suchorska B; Wenter V; Schmid-Tannwald C; Mille E; Todica A; Brendel M; Tonn JC; Bartenstein P; la Fougère C
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1105-14. PubMed ID: 26666239
[TBL] [Abstract][Full Text] [Related]
5. Combination of MRI and dynamic FET PET for initial glioma grading.
Dunet V; Maeder P; Nicod-Lalonde M; Lhermitte B; Pollo C; Bloch J; Stupp R; Meuli R; Prior JO
Nuklearmedizin; 2014 Aug; 53(4):155-61. PubMed ID: 24737132
[TBL] [Abstract][Full Text] [Related]
6. Role of O-(2-18F-fluoroethyl)-L-tyrosine PET as a diagnostic tool for detection of malignant progression in patients with low-grade glioma.
Galldiks N; Stoffels G; Ruge MI; Rapp M; Sabel M; Reifenberger G; Erdem Z; Shah NJ; Fink GR; Coenen HH; Langen KJ
J Nucl Med; 2013 Dec; 54(12):2046-54. PubMed ID: 24159047
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma.
Rapp M; Heinzel A; Galldiks N; Stoffels G; Felsberg J; Ewelt C; Sabel M; Steiger HJ; Reifenberger G; Beez T; Coenen HH; Floeth FW; Langen KJ
J Nucl Med; 2013 Feb; 54(2):229-35. PubMed ID: 23232275
[TBL] [Abstract][Full Text] [Related]
9. Relationship of regional cerebral blood flow and kinetic behaviour of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake in cerebral gliomas.
Zhang K; Langen KJ; Neuner I; Stoffels G; Filss C; Galldiks N; Tellmann L; Rota Kops E; Coenen HH; Herzog H; Shah NJ
Nucl Med Commun; 2014 Mar; 35(3):245-51. PubMed ID: 24240195
[TBL] [Abstract][Full Text] [Related]
10. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods?
Pöpperl G; Kreth FW; Herms J; Koch W; Mehrkens JH; Gildehaus FJ; Kretzschmar HA; Tonn JC; Tatsch K
J Nucl Med; 2006 Mar; 47(3):393-403. PubMed ID: 16513607
[TBL] [Abstract][Full Text] [Related]
11. FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading.
Pöpperl G; Kreth FW; Mehrkens JH; Herms J; Seelos K; Koch W; Gildehaus FJ; Kretzschmar HA; Tonn JC; Tatsch K
Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):1933-42. PubMed ID: 17763848
[TBL] [Abstract][Full Text] [Related]
12. Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for glioma grading: assessment of individual probability of malignancy.
Calcagni ML; Galli G; Giordano A; Taralli S; Anile C; Niesen A; Baum RP
Clin Nucl Med; 2011 Oct; 36(10):841-7. PubMed ID: 21892031
[TBL] [Abstract][Full Text] [Related]
13. Uptake and tracer kinetics of O-(2-(18)F-fluoroethyl)-L-tyrosine in meningiomas: preliminary results.
Cornelius JF; Stoffels G; Filß C; Galldiks N; Slotty P; Kamp M; el Khatib M; Hänggi D; Sabel M; Felsberg J; Steiger HJ; Coenen HH; Shah NJ; Langen KJ
Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):459-67. PubMed ID: 25331459
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas.
Röhrich M; Huang K; Schrimpf D; Albert NL; Hielscher T; von Deimling A; Schüller U; Dimitrakopoulou-Strauss A; Haberkorn U
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1573-1584. PubMed ID: 29732524
[TBL] [Abstract][Full Text] [Related]
15. Comparison of
Unterrainer M; Fleischmann DF; Diekmann C; Vomacka L; Lindner S; Vettermann F; Brendel M; Wenter V; Ertl-Wagner B; Herms J; Wetzel C; Rupprecht R; Tonn JC; Belka C; Bartenstein P; Niyazi M; Albert NL
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):580-590. PubMed ID: 30244386
[TBL] [Abstract][Full Text] [Related]
16. Comparison of (18)F-FET and (18)F-FDG PET in brain tumors.
Pauleit D; Stoffels G; Bachofner A; Floeth FW; Sabel M; Herzog H; Tellmann L; Jansen P; Reifenberger G; Hamacher K; Coenen HH; Langen KJ
Nucl Med Biol; 2009 Oct; 36(7):779-87. PubMed ID: 19720290
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive prediction of IDH-wildtype genotype in gliomas using dynamic
Vettermann F; Suchorska B; Unterrainer M; Nelwan D; Forbrig R; Ruf V; Wenter V; Kreth FW; Herms J; Bartenstein P; Tonn JC; Albert NL
Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2581-2589. PubMed ID: 31410540
[TBL] [Abstract][Full Text] [Related]
18. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
[TBL] [Abstract][Full Text] [Related]
19. Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis.
Galldiks N; Stoffels G; Filss CP; Piroth MD; Sabel M; Ruge MI; Herzog H; Shah NJ; Fink GR; Coenen HH; Langen KJ
J Nucl Med; 2012 Sep; 53(9):1367-74. PubMed ID: 22872742
[TBL] [Abstract][Full Text] [Related]
20. Flare Phenomenon in
Filss CP; Schmitz AK; Stoffels G; Stegmayr C; Lohmann P; Werner JM; Sabel M; Rapp M; Goldbrunner R; Neumaier B; Mottaghy FM; Shah NJ; Fink GR; Galldiks N; Langen KJ
J Nucl Med; 2020 Sep; 61(9):1294-1299. PubMed ID: 32005771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
